Cartilage oligomeric matrix protein and hyaluronan levels in synovial fluid from horses with osteoarthritis of the tarsometatarsal joint compared to a control population.
Authors: Taylor S E, Weaver M P, Pitsillides A A, Wheeler B T, Wheeler-Jones C P D, Shaw D J, Smith R K W
Journal: Equine veterinary journal
Summary
# Editorial Summary Cartilage oligomeric matrix protein (COMP) in synovial fluid has potential as a biomarker for tarsometatarsal joint disease, though hyaluronan appears less useful for this purpose. Taylor and colleagues collected synovial fluid from 25 sound horses and 25 lame horses with radiographically confirmed osteoarthritis (OA) of the tarsometatarsal joint, measuring COMP and hyaluronan concentrations via ELISA and performing immunoblotting to identify protein fragmentation patterns. COMP concentrations were significantly lower in affected joints compared to controls, with immunoblots revealing a characteristic 30 kDa COMP fragment present only in horses with OA; conversely, hyaluronan levels and HA:COMP ratios showed no significant differences between groups, and neither marker correlated with radiographic severity scores. For practitioners, these findings suggest that decreased synovial COMP levels reflect substantial cartilage loss in established tarsometatarsal OA, but a single COMP measurement cannot reliably stage disease progression; development of assays specifically targeting the OA-associated COMP fragment may offer greater diagnostic sensitivity and enable earlier detection of this commercially significant condition in performance horses. Further research linking longitudinal COMP fragment data to clinical outcomes and treatment response would strengthen the case for routine synovial fluid biomarker monitoring in tarsal joint disease management.
Read the full abstract on PubMed
Practical Takeaways
- •Decreased COMP in synovial fluid indicates cartilage loss in established tarsometatarsal OA, but single measurements cannot stage disease progression
- •The specific COMP fragment (30 kDa) may offer potential for earlier clinical detection of OA if assay development is pursued, potentially enabling intervention before radiographic changes become apparent
- •Hyaluronan measurement alone is not a useful synovial fluid biomarker for monitoring tarsometatarsal OA in horses
Key Findings
- •COMP concentrations in synovial fluid from OA-affected tarsometatarsal joints were significantly lower than in control horses
- •A specific COMP fragment of approximately 30 kDa was identified only in horses with OA, not in controls
- •Hyaluronan concentration and HA:COMP ratio showed no significant difference between lame and control horses
- •No correlation existed between synovial fluid COMP/HA levels and radiographic severity of OA